These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16023320)

  • 1. [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
    Gehanno P; Pessey JJ; Serrano E
    Med Mal Infect; 2005 Jun; 35(6):335-43. PubMed ID: 16023320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Sydnor TA; Kopp EJ; Anthony KE; LoCoco JM; Kim SS; Fowler CL
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
    Anon JB; Paglia M; Xiang J; Ambrose PG; Jones RN; Kahn JB
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):105-7. PubMed ID: 17178300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid.
    Brook I; Foote PA; Hausfeld JN
    Int J Antimicrob Agents; 2005 Nov; 26(5):416-9. PubMed ID: 16226017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
    Adelglass J; Jones TM; Ruoff G; Kahn JB; Wiesinger BA; Rielly-Gauvin K; Siu CO
    Pharmacotherapy; 1998; 18(6):1255-63. PubMed ID: 9855324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management.
    Anon JB
    Paediatr Drugs; 2003; 5 Suppl 1():25-33. PubMed ID: 14632103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
    Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A
    East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Murray JJ; Emparanza P; Lesinskas E; Tawadrous M; Breen JD
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiology of sinusitis and the predictive value of throat culture for the aetiology of sinusitis.
    Ilki A; Ulger N; Inanli S; Ozer E; Arikan C; Bakir M; Soyletir G
    Clin Microbiol Infect; 2005 May; 11(5):407-10. PubMed ID: 15819870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC; Kapral D; Busman TA; Paris MM
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial findings in acute maxillary sinusitis--European study.
    Penttilä M; Savolainen S; Kiukaanniemi H; Forsblom B; Jousimies-Somer H
    Acta Otolaryngol Suppl; 1997; 529():165-8. PubMed ID: 9288300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of sinusitis seen in hospitalized patients. Apropos of 77 episodes of sinusitis among 72 patients between 1993 and 1996].
    Fasquelle D; Alami M; Dumas G; Fockenier F; Sibille JP
    Pathol Biol (Paris); 1998 Dec; 46(10):751-9. PubMed ID: 9922991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
    Klossek JM; Siegert R; Nikolaidis P; Arvis P; Leberre MA;
    J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis.
    Poole M; Anon J; Paglia M; Xiang J; Khashab M; Kahn J
    Otolaryngol Head Neck Surg; 2006 Jan; 134(1):10-7. PubMed ID: 16399173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective study of 43 severe complications of acute rhinosinusitis].
    Stoll D; Klossek JM; Barbaza MO;
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(4):195-201. PubMed ID: 17315782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.